Other Species / Isoforms
  EIF3E (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K29-ub
LLEFLSVkEIYNEkE
0 2
EIF3E (human) LLEFLSVkEIYNEkE K29-ub
EIF3E (mouse) LLEFLSVKEIYNEkE K29
EIF3E (rat) LLEFLSVKEIYNEKE K29
K35-ac
VkEIYNEkELLQGkL
0 1
EIF3E (human) VkEIYNEkELLQGkL K35-ac
EIF3E (mouse) VKEIYNEkELLQGKL K35-ac
EIF3E (rat) VKEIYNEKELLQGKL K35
K35-ub
VkEIYNEkELLQGkL
0 6
EIF3E (human) VkEIYNEkELLQGkL K35-ub
EIF3E (mouse) VKEIYNEkELLQGKL K35-ub
EIF3E (rat) VKEIYNEKELLQGKL K35
K41-ub
EkELLQGkLDLLSDT
0 8
EIF3E (human) EkELLQGkLDLLSDT K41-ub
EIF3E (mouse) EkELLQGKLDLLSDT K41
EIF3E (rat) EKELLQGKLDLLSDT K41
K59-ub
DFAMDVYkNLySDDI
0 1
EIF3E (human) DFAMDVYkNLySDDI K59-ub
EIF3E (mouse) DFAMDVYKNLYSDDI K59
EIF3E (rat) DFAMDVYKNLYSDDI K59
Y62-p
MDVYkNLySDDIPHA
0 1
EIF3E (human) MDVYkNLySDDIPHA Y62-p
EIF3E (mouse) MDVYKNLYSDDIPHA Y62
EIF3E (rat) MDVYKNLYSDDIPHA Y62
K82-ub
TTVVAQLkQLQAETE
Upstream
0 21
Treatment
  • MG132
EIF3E (human) TTVVAQLkQLQAETE K82-ub
EIF3E (mouse) TTVVAQLkQLQAETE K82-ub
EIF3E (rat) TTVVAQLKQLQAETE K82
K93-ub
AETEPIVkMFEDPET
0 10
EIF3E (human) AETEPIVkMFEDPET K93-ub
EIF3E (mouse) AETEPIVkMFEDPET K93-ub
EIF3E (rat) AETEPIVKMFEDPET K93
Y116-p
DGRMLFDyLADkHGF
0 1
EIF3E (human) DGRMLFDyLADkHGF Y116-p
EIF3E (mouse) DGRMLFDYLADKHGF Y116
EIF3E (rat) DGRMLFDYLADKHGF Y116
K120-ub
LFDyLADkHGFRQEY
0 7
EIF3E (human) LFDyLADkHGFRQEY K120-ub
EIF3E (mouse) LFDYLADKHGFRQEY K120
EIF3E (rat) LFDYLADKHGFRQEY K120
T161-p
FRVLVPAtDrNALSS
0 1
EIF3E (human) FRVLVPAtDrNALSS T161-p
EIF3E (mouse) FRVLVPATDRNALSS T161
EIF3E (rat) FRVLVPATDRNALSS T161
R163-m1
VLVPAtDrNALSSLW
0 1
EIF3E (human) VLVPAtDrNALSSLW R163-m1
EIF3E (mouse) VLVPATDRNALSSLW R163
EIF3E (rat) VLVPATDRNALSSLW R163
K193-ac
MEDLTRLkETIDNNS
0 1
EIF3E (human) MEDLTRLkETIDNNS K193-ac
EIF3E (mouse) MEDLTRLKETIDNNS K193
EIF3E (rat) MEDLTRLKETIDNNS K193
K193-ub
MEDLTRLkETIDNNS
0 5
EIF3E (human) MEDLTRLkETIDNNS K193-ub
EIF3E (mouse) MEDLTRLKETIDNNS K193
EIF3E (rat) MEDLTRLKETIDNNS K193
T263
YLTTAVITNkDVRKR
0 1
EIF3E (human) YLTTAVITNkDVRKR T263
EIF3E (mouse) YLTTAVItNkDVRKR T263-p
EIF3E (rat) YLTTAVITNKDVRKR T263
K265
TTAVITNKDVRKRRQ
0 1
EIF3E (human) TTAVITNKDVRKRRQ K265
EIF3E (mouse) TTAVItNkDVRKRRQ K265-ac
EIF3E (rat) TTAVITNKDVRKRRQ K265
K265-ub
TTAVITNkDVRKRRQ
0 7
EIF3E (human) TTAVITNkDVRKRRQ K265-ub
EIF3E (mouse) TTAVItNKDVRKRRQ K265
EIF3E (rat) TTAVITNKDVRKRRQ K265
K275-ac
RKRRQVLkDLVkVIQ
0 4
EIF3E (human) RKRRQVLkDLVkVIQ K275-ac
EIF3E (mouse) RKRRQVLKDLVKVIQ K275
EIF3E (rat) RKRRQVLkDLVKVIQ K275-ac
K275-ub
RKRRQVLkDLVkVIQ
0 3
EIF3E (human) RKRRQVLkDLVkVIQ K275-ub
EIF3E (mouse) RKRRQVLkDLVKVIQ K275-ub
EIF3E (rat) RKRRQVLKDLVKVIQ K275
K279-ub
QVLkDLVkVIQQESy
0 2
EIF3E (human) QVLkDLVkVIQQESy K279-ub
EIF3E (mouse) QVLkDLVKVIQQESY K279
EIF3E (rat) QVLkDLVKVIQQESY K279
Y286-p
kVIQQESyTYKDPIT
0 1
EIF3E (human) kVIQQESyTYKDPIT Y286-p
EIF3E (mouse) KVIQQESYTYKDPIT Y286
EIF3E (rat) KVIQQESYTYKDPIT Y286
K359-ub
SINMLADkLNMTPEE
0 1
EIF3E (human) SINMLADkLNMTPEE K359-ub
EIF3E (mouse) SINMLADKLNMTPEE K359
EIF3E (rat) SINMLADKLNMTPEE K359
K383-ub
RNARLDAkIDSkLGH
0 10
EIF3E (human) RNARLDAkIDSkLGH K383-ub
EIF3E (mouse) RNARLDAKIDSkLGH K383
EIF3E (rat) RNARLDAKIDSKLGH K383
K387-ub
LDAkIDSkLGHVVMG
Upstream
0 11
Treatment
  • MG132
EIF3E (human) LDAkIDSkLGHVVMG K387-ub
EIF3E (mouse) LDAKIDSkLGHVVMG K387-ub
EIF3E (rat) LDAKIDSKLGHVVMG K387
S399-p
VMGNNAVsPyQQVIE
Upstream
0 45
Treatment
  • nocodazole
EIF3E (human) VMGNNAVsPyQQVIE S399-p
EIF3E (mouse) VMGNNAVsPyQQVIE S399-p
EIF3E (rat) VMGNNAVSPYQQVIE S399
Y401-p
GNNAVsPyQQVIEkT
0 90
EIF3E (human) GNNAVsPyQQVIEkT Y401-p
EIF3E (mouse) GNNAVsPyQQVIEkT Y401-p
EIF3E (rat) GNNAVSPYQQVIEKT Y401
K407-ub
PyQQVIEkTksLsFR
0 7
EIF3E (human) PyQQVIEkTksLsFR K407-ub
EIF3E (mouse) PyQQVIEkTkSLsFR K407-ub
EIF3E (rat) PYQQVIEKTKSLSFR K407
K409-ub
QQVIEkTksLsFRSQ
Upstream
0 9
Treatment
  • MG132
EIF3E (human) QQVIEkTksLsFRSQ K409-ub
EIF3E (mouse) QQVIEkTkSLsFRSQ K409-ub
EIF3E (rat) QQVIEKTKSLSFRSQ K409
K409-sm
QQVIEkTksLsFRSQ
0 1
EIF3E (human) QQVIEkTksLsFRSQ K409-sm
EIF3E (mouse) QQVIEkTKSLsFRSQ K409
EIF3E (rat) QQVIEKTKSLSFRSQ K409
S410-p
QVIEkTksLsFRSQM
0 1
EIF3E (human) QVIEkTksLsFRSQM S410-p
EIF3E (mouse) QVIEkTkSLsFRSQM S410
EIF3E (rat) QVIEKTKSLSFRSQM S410
S412-p
IEkTksLsFRSQMLA
0 14
EIF3E (human) IEkTksLsFRSQMLA S412-p
EIF3E (mouse) IEkTkSLsFRSQMLA S412-p
EIF3E (rat) IEKTKSLSFRSQMLA S412
K424-ub
MLAMNIEkkLNQNSR
Upstream
0 8
Treatment
  • MG132
EIF3E (human) MLAMNIEkkLNQNSR K424-ub
EIF3E (mouse) MLAMNIEKKLNQNSR K424
EIF3E (rat) MLAMNIEKKLNQNSR K424
K425-ub
LAMNIEkkLNQNSRS
0 6
EIF3E (human) LAMNIEkkLNQNSRS K425-ub
EIF3E (mouse) LAMNIEKKLNQNSRS K425
EIF3E (rat) LAMNIEKKLNQNSRS K425
K425-ac
LAMNIEkkLNQNSRS
0 1
EIF3E (human) LAMNIEkkLNQNSRS K425-ac
EIF3E (mouse) LAMNIEKKLNQNSRS K425
EIF3E (rat) LAMNIEKKLNQNSRS K425
T439-p
SEAPNWAtQDsGFy_
0 2
EIF3E (human) SEAPNWAtQDsGFy_ T439-p
EIF3E (mouse) SEAPNWATQDSGFy_ T439
EIF3E (rat) SEAPNWATQDsGFY_ T439
S442-p
PNWAtQDsGFy____
0 13
EIF3E (human) PNWAtQDsGFy____ S442-p
EIF3E (mouse) PNWATQDSGFy____ S442
EIF3E (rat) PNWATQDsGFY____ S442-p
Y445-p
AtQDsGFy_______
0 122
EIF3E (human) AtQDsGFy_______ Y445-p
EIF3E (mouse) ATQDSGFy_______ Y445-p
EIF3E (rat) ATQDsGFY_______ Y445